![Christy Oliger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christy Oliger
Direktor/Vorstandsmitglied bei KARYOPHARM THERAPEUTICS INC.
Vermögen: 113 476 $ am 31.05.2024
Aktive Positionen von Christy Oliger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 28.08.2020 | - |
Independent Dir/Board Member | 28.08.2020 | - | |
REPLIMUNE GROUP, INC. | Direktor/Vorstandsmitglied | 01.12.2021 | - |
Independent Dir/Board Member | 01.12.2021 | - | |
LAVA THERAPEUTICS N.V. | Direktor/Vorstandsmitglied | 09.03.2023 | - |
VERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.06.2024 | - |
Karriereverlauf von Christy Oliger
Ehemalige bekannte Positionen von Christy Oliger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RAYZEBIO, INC. | Direktor/Vorstandsmitglied | 01.08.2023 | 26.02.2024 |
REATA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.04.2021 | 26.09.2023 |
Independent Dir/Board Member | 15.04.2021 | 26.09.2023 | |
SIERRA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 02.06.2021 | 01.07.2022 |
Independent Dir/Board Member | 02.06.2021 | 01.07.2022 | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2017 | 01.07.2020 |
Ausbildung von Christy Oliger
University of California, Santa Barbara | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Niederlande | 2 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 4 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 9 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
LAVA THERAPEUTICS N.V. | Health Technology |
RAYZEBIO, INC. | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
![]() Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Sierra Oncology, Inc.
![]() Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
- Börse
- Insiders
- Christy Oliger
- Erfahrung